Xtant Medical Announces Appointment of Chief Operations Officer
January 11 2019 - 9:00AM
Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global
medical technology company focused on surgical solutions for the
treatment of spinal disorders, announced today the appointment
of Ronald Berlin as Vice President & Chief Operations
Officer, effective January 1, 2019. Mr. Berlin will report to
Michael Mainelli, Xtant’s Interim Chief Executive Officer.
“Ron is an accomplished healthcare executive
with significant operations and quality management expertise and we
are pleased that he has joined our executive management team,” said
Michael Mainelli. “In addition to the operational leadership he
will provide to the organization, he is a strong strategic,
cross-functional leader. His appointment continues our commitment
to building a highly skilled management team.”
Ron Berlin brings over 35 years of operations
experience to Xtant. Most recently, Mr. Berlin served as Vice
President of Global Operations for CoorsTek Medical. Prior to that
role, he held positions of Vice President, Global Strategic
Sourcing and Procurement and Vice President, Operations for Integra
LifeSciences. Earlier in his career, he was Vice President of
Global Operations at Stryker Orthopaedics, which was at the time a
division of Stryker Corporation. He is well versed in all aspects
of medical device and tissue processing operations and quality
assurance. He has a proven track record for improving compliance
and quality, cost effectiveness, asset utilization, and continuous
improvement programs based on Six Sigma, Kaizen, Lean
Implementation, as well as managing the implementation of M&A
programs.
“I’m particularly pleased to be joining this
exceptional, newly appointed executive leadership team and look
forward to helping the Company continue to transform its business
and drive shareholder value”, said Ron Berlin.
About Xtant Medical Holdings,
Inc.
Xtant Medical Holdings,
Inc. (www.xtantmedical.com) is a global medical technology
company focused on the design, development, and commercialization
of a comprehensive portfolio of orthobiologics and spinal implant
systems to facilitate spinal fusion in complex spine, deformity and
degenerative procedures. Xtant people are dedicated and talented,
operating with the highest integrity to serve our customers.
COMPANY CONTACTKathie Lenzen, Chief Financial
Officer406.388.0480klenzen@xtantmedical.com
Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Xtant Medical (AMEX:XTNT)
Historical Stock Chart
From Apr 2023 to Apr 2024